Author(s): Dupuis A, Tournier N, Le Moal G, Venisse N
Abstract Share this page
Abstract The combined systemic and topical administration of voriconazole has successfully been used to treat keratomycosis. Because no voriconazole eye drop product is commercially available, we prepared a sterile eye drop solution (10 mg/ml). Voriconazole remains stable over 30 days, providing an eye drop solution suitable for use for the topical treatment of fungal keratitis.
This article was published in Antimicrob Agents Chemother
and referenced in Fungal Genomics & Biology